| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/27/2003 | WO2002014830A3 Method of identification and quantification of biological molecules and apparatus therefore |
| 03/27/2003 | WO2002012902A3 Split-ubiquitin based reporter systems and methods of their use |
| 03/27/2003 | WO2002012340A3 Transporters and ion channels |
| 03/27/2003 | WO2002010445A2 Method for determining the age of individuals |
| 03/27/2003 | WO2002009750A3 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene |
| 03/27/2003 | WO2002005857A3 Phosphatonin-related gene and methods of use thereof |
| 03/27/2003 | WO2002004682A3 Polymorphisms in a diacylglycerol acyltransferase gene, and methods of use thereof |
| 03/27/2003 | WO2002002817A3 Multipartite high-affinity nucleic acid probes |
| 03/27/2003 | WO2002000692A3 Pd-l2 molecules: pd-1 ligands and uses therefor |
| 03/27/2003 | WO2001079557A3 Gtp-binding protein useful in treatment and detection of cancer |
| 03/27/2003 | WO2001079419A3 Cellular arrays for the identification of altered gene expression |
| 03/27/2003 | WO2001077390A3 Process for allele discrimation utilizing primer extension |
| 03/27/2003 | WO2001062954A3 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 03/27/2003 | WO2001061346A3 Methods for identifying agents causing a lethal phenotype |
| 03/27/2003 | US20030061626 Characterisation of gene function using double stranded RNA inhibition |
| 03/27/2003 | US20030061625 Modulation of PDE11A activity |
| 03/27/2003 | US20030060620 Methods and apparatus for the recovery of nucleic acids |
| 03/27/2003 | US20030060619 Antibody for use in the disgnosis and treatment of kidney, urogenital, and sex disorders |
| 03/27/2003 | US20030060618 Nucleotide sequences coding polypeptide for use in the treatment of and prevention of lyme disease |
| 03/27/2003 | US20030060617 Diagnosing nervous system disorders in humans; obtain sample, screen for the presence of aberrant glutamate receptor, presence of receptor indicates nervous system disorder |
| 03/27/2003 | US20030060616 Type II IL-1 receptors |
| 03/27/2003 | US20030060437 Antisense modulation of dual specific phosphatase 5 expression |
| 03/27/2003 | US20030060431 Base analogues |
| 03/27/2003 | US20030060417 Novel gene having reverse transcriptase motif |
| 03/27/2003 | US20030060410 Use of HMG fragments as anti-inflammatory agents |
| 03/27/2003 | US20030060407 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/27/2003 | US20030060406 Nucleotide sequence that encodes an amino acid sequence by culturing the host cell for expression of polypeptide; agonist or antagonist |
| 03/27/2003 | US20030060032 Microelectronic unit forming methods and materials |
| 03/27/2003 | US20030059955 Affinity tag modified particles |
| 03/27/2003 | US20030059949 Droplet dispensing system |
| 03/27/2003 | US20030059929 Apparatus for use in the preparation or analysis of biopolymers |
| 03/27/2003 | US20030059922 Sphingosine1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 03/27/2003 | US20030059921 Novel clot-specific steptokinase proteins possessing altered plasminogen activation characteristics and a process for the preparation of said proteins |
| 03/27/2003 | US20030059917 Mixture containing preferential polypeptide for use in treatment of tumors |
| 03/27/2003 | US20030059916 IRAK-4: compositions and methods of use |
| 03/27/2003 | US20030059909 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 03/27/2003 | US20030059908 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and cardiovascular disorders |
| 03/27/2003 | US20030059886 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of tumor and cell proliferative disorders |
| 03/27/2003 | US20030059885 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of tumor and cell proliferative disorders |
| 03/27/2003 | US20030059883 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/27/2003 | US20030059882 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/27/2003 | US20030059880 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/27/2003 | US20030059879 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/27/2003 | US20030059875 Nucleotide sequences coding polypeptide for use in the treatment prevention and diagnosis of inflammatory blood and cancer disorders |
| 03/27/2003 | US20030059873 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans |
| 03/27/2003 | US20030059869 Novel G protein-coupled receptor, GAVE3 |
| 03/27/2003 | US20030059867 Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon |
| 03/27/2003 | US20030059866 Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon |
| 03/27/2003 | US20030059863 N-terminally truncated HER-2/neu protein as a cancer prognostic indicator |
| 03/27/2003 | US20030059850 Fluorescence proximity assay |
| 03/27/2003 | US20030059848 Detection of protein which bind to circadian rhythm proteins; obtain sample containing circadian rhythm protein, incubate with test compounds, detect bound protein, presence of bound protein indicates circadian rhythm protein |
| 03/27/2003 | US20030059847 Generation of flurogenic substrates; couple fluorogenic compounds to solid support, join substrate to solid support, expose to ammonia and release flurogenic substrate from support |
| 03/27/2003 | US20030059845 Novel human dopamine receptor and its uses |
| 03/27/2003 | US20030059836 Rapid quantitative measurement of soluble fibrin in opaque body fluids |
| 03/27/2003 | US20030059835 Nucleotide sequence coding red fluorescent protein for use as diagnostic tool in genetic analysis |
| 03/27/2003 | US20030059833 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders |
| 03/27/2003 | US20030059832 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders |
| 03/27/2003 | US20030059831 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders |
| 03/27/2003 | US20030059829 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and skin disorders |
| 03/27/2003 | US20030059828 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and skin disorders |
| 03/27/2003 | US20030059824 Drug targets for alzheimer's disease and other diseases associated with decreased neuronal metabolism |
| 03/27/2003 | US20030059822 Differential tagging of polymers for high resolution linear analysis |
| 03/27/2003 | US20030059820 Apparatus for use in the detection of preferential particles in sample |
| 03/27/2003 | US20030059819 Combination of epoxy and amine silanes for immobilizing and hybridizing nucleic acid molecules on a solid support |
| 03/27/2003 | US20030059817 Inkjet method of spotting probe and manufacturing a probe array |
| 03/27/2003 | US20030059816 Methods for identifying racemases |
| 03/27/2003 | US20030059815 Detection of preferential nuceotide sequences in polynucleotide; obtain polynucleotide, cut with enzymes, ligate adaptors, determine sequences between adaptors |
| 03/27/2003 | US20030059814 Detecting binding between biopolymers; provide binding biopolymers, incubate with probe, monitor enzyme activity, presence of enzyme activity indicates bound biopolymers |
| 03/27/2003 | US20030059813 Kit for detecting preferential polymorphisms in nucleotide sequences |
| 03/27/2003 | US20030059812 HDAC9 polypeptides and polynucleotides and uses thereof |
| 03/27/2003 | US20030059810 Detection of preferential sequences in polynucleotide; obtain nucleotide sequence, incubate with probe, fractionate, separate with electrophoresis, record pattern |
| 03/27/2003 | US20030059809 Biochips,preparation and uses |
| 03/27/2003 | US20030059808 Haplotype determination |
| 03/27/2003 | US20030059807 Microcalorimetric detection of analytes and binding events |
| 03/27/2003 | US20030059806 Nucleotide sequences for use in the detection of viral nucleotide sequences and infection |
| 03/27/2003 | US20030059805 Nucleotide sequences coding polyeptide for use in the treatment of growth disorders in humans |
| 03/27/2003 | US20030059801 In situ amplification of a target nucleic acid; obtain fixed cell, incubate with endonuclease, expose to nuclease, incubate wth polymerase and primers, amplify, recover amplification product |
| 03/27/2003 | US20030059800 Nucleotide sequences coding polypeptide for use in in vitro models for drug metabolism; for use in detection of toxins in environment |
| 03/27/2003 | US20030059798 Apparatus and method for detecting and identifying infectious agents |
| 03/27/2003 | US20030059796 Detecting genes associated with controlling angiogenesis; obtain and culture endothelial cells, isolate ribonucleic acids, amplified or reduced concentrations of preferenial ribonucleic acids indicate association with angiogenesis |
| 03/27/2003 | US20030059795 Method for accelerated genome walking and DNA fingerprinting |
| 03/27/2003 | US20030059794 Adenoviral library assay for E2F regulatory genes and methods and compositions for screening compounds |
| 03/27/2003 | US20030059793 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof |
| 03/27/2003 | US20030059792 Apparatus for use as tool in screening genetic data in computers which is associated with signal transduction |
| 03/27/2003 | US20030059791 Solid support join to preferential oligonucleotide for use as diagnostic tool in genetic analysis |
| 03/27/2003 | US20030059790 Evalating human for cancer recurrence; obtain tumor cell from human, incubate with probe, count concentration of cancer gene in cells, evaluate for recurrence of cancer |
| 03/27/2003 | US20030059788 Evaluating toxicity of compound; obtain cells, incubate with test agent, extract nucleotide sequence, hybridize with probe, monitor hybridization profile, compare to control, similarities in pattern indicate toxicity |
| 03/27/2003 | US20030059786 Nucleic acid detection using structured probes |
| 03/27/2003 | US20030059785 Detection of markers in nascent proteins |
| 03/27/2003 | US20030059783 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/27/2003 | US20030059782 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system and cancer diseases |
| 03/27/2003 | US20030059781 Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer |
| 03/27/2003 | US20030059780 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system and cancer diseases |
| 03/27/2003 | US20030059779 Promotor for functional characterization of G-protein coupled receptors in the yeast saccharomyces cerevisiae |
| 03/27/2003 | US20030059778 Nucleic acid sequencing by Raman monitoring of uptake of precursors during molecular replication |
| 03/27/2003 | US20030059777 Detection of preferential nucleotide sequences in sample; provide nanoparticles having oligonucleotides attached, incubate with nucleotide sequence sample, detect adjustment in hybridization pattern |
| 03/27/2003 | US20030059776 bbc3 gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter |
| 03/27/2003 | US20030059774 Screening metabolism of preferential substrates; obtain nucleotide sequence from human, detect polymorphisms in sequence, express sequences, monitor protein activity |
| 03/27/2003 | US20030059772 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/27/2003 | US20030059771 Compositions and methods related to the Rig tumor suppressor gene and protein |